Johnson & Johnson Earnings Per Share (Basic)
Johnson & Johnson (JNJ) reported Earnings Per Share (Basic) of $2.30 per share for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-07-23.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-07-23
- Johnson & Johnson earnings per share, basic for the quarter ending 2026-06-28 was $2.30, a 0.00% change year-over-year.
- Johnson & Johnson earnings per share, basic for the quarter ending 2026-03-29 was $2.17, a 52.52% decline year-over-year.
- Johnson & Johnson earnings per share, basic for the quarter ending 2025-12-28 was $2.12, a 49.07% increase year-over-year.
- Johnson & Johnson earnings per share, basic for the quarter ending 2025-09-28 was $2.14, a 91.07% increase year-over-year.
- Johnson & Johnson earnings per share, basic for fiscal 2025 was $11.13, a 90.58% increase from fiscal 2024.
- Johnson & Johnson earnings per share, basic for fiscal 2024 was $5.84, a 57.93% decline from fiscal 2023.
- Johnson & Johnson earnings per share, basic for fiscal 2023 was $13.88, a 103.22% increase from fiscal 2023.
- Johnson & Johnson earnings per share, basic for fiscal 2023 was $6.83, a 13.87% decline from fiscal 2022.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-28 | $2.30 10-Q · filed 2026-07-23 | $4.47 10-Q · filed 2026-07-23 | $6.60 derived: net income ÷ weighted average shares · filed 2026-07-23 | $8.74 derived: net income ÷ weighted average shares · filed 2026-07-23 | |
| 2026-03-29 | $2.17 10-Q · filed 2026-04-22 | $4.30 derived: net income ÷ weighted average shares · filed 2026-04-22 | $6.44 derived: net income ÷ weighted average shares · filed 2026-04-22 | $8.74 derived: net income ÷ weighted average shares · filed 2026-07-23 | |
| 2025-12-28 | $2.12 derived: net income ÷ weighted average shares · filed 2026-02-11 | $4.26 derived: net income ÷ weighted average shares · filed 2026-02-11 | $6.57 derived: net income ÷ weighted average shares · filed 2026-07-23 | $11.13 10-K · filed 2026-02-11 | |
| 2025-09-28 | $2.14 10-Q · filed 2025-10-22 | $4.44 derived: net income ÷ weighted average shares · filed 2026-07-23 | $9.01 10-Q · filed 2025-10-22 | $10.43 derived: net income ÷ weighted average shares · filed 2026-07-23 | |
| 2025-06-29 | $2.30 10-Q · filed 2026-07-23 | $6.87 10-Q · filed 2026-07-23 | $8.30 derived: net income ÷ weighted average shares · filed 2026-07-23 | $9.41 derived: net income ÷ weighted average shares · filed 2026-07-23 | |
| 2025-03-30 | $4.57 10-Q · filed 2026-04-22 | $5.99 derived: net income ÷ weighted average shares · filed 2026-04-22 | $7.11 derived: net income ÷ weighted average shares · filed 2026-04-22 | $9.06 derived: net income ÷ weighted average shares · filed 2026-04-22 | |
| 2024-12-29 | $1.43 derived: net income ÷ weighted average shares · filed 2026-02-11 | $2.54 derived: net income ÷ weighted average shares · filed 2026-02-11 | $4.49 derived: net income ÷ weighted average shares · filed 2026-02-11 | $5.84 10-K · filed 2026-02-11 | |
| 2024-09-29 | $1.12 10-Q · filed 2025-10-22 | $3.07 derived: net income ÷ weighted average shares · filed 2025-10-22 | $4.42 10-Q · filed 2025-10-22 | $6.10 derived: net income ÷ weighted average shares · filed 2026-02-11 | |
| 2024-06-30 | $1.95 10-Q · filed 2025-07-24 | $3.30 10-Q · filed 2025-07-24 | $4.98 derived: net income ÷ weighted average shares · filed 2026-02-11 | $15.60 derived: net income ÷ weighted average shares · filed 2026-02-11 | |
| 2024-03-31 | $1.35 10-Q · filed 2025-04-23 | $3.03 derived: net income ÷ weighted average shares · filed 2026-02-11 | $13.63 derived: net income ÷ weighted average shares · filed 2026-02-11 | $15.49 derived: net income ÷ weighted average shares · filed 2026-02-11 | |
| 2023-12-31 | $1.68 10-K · filed 2024-02-16 | $12.20 derived: net income ÷ weighted average shares · filed 2026-02-11 | $14.04 derived: net income ÷ weighted average shares · filed 2026-02-11 | $13.88 10-K · filed 2026-02-11 | |
| 2023-10-01 | $10.32 10-Q · filed 2024-10-23 | $12.17 derived: net income ÷ weighted average shares · filed 2024-10-23 | $12.08 10-Q · filed 2024-10-23 | $13.39 derived: net income ÷ weighted average shares · filed 2025-02-13 | |
| 2023-07-02 | $1.98 10-Q · filed 2024-07-25 | $1.95 10-Q · filed 2024-07-25 | $3.30 derived: net income ÷ weighted average shares · filed 2025-02-13 | $5.00 derived: net income ÷ weighted average shares · filed 2025-02-13 | |
| 2023-04-02 | -$0.03 10-Q · filed 2024-05-01 | $1.32 derived: net income ÷ weighted average shares · filed 2025-02-13 | $3.02 derived: net income ÷ weighted average shares · filed 2025-02-13 | $4.86 derived: net income ÷ weighted average shares · filed 2025-02-13 | |
| 2023-01-01 | $1.35 10-K · filed 2024-02-16 | $3.04 derived: net income ÷ weighted average shares · filed 2025-02-13 | $4.88 derived: net income ÷ weighted average shares · filed 2025-02-13 | $6.83 10-K · filed 2025-02-13 | |
| 2022-10-02 | $1.70 10-K · filed 2024-02-16 | $3.53 derived: net income ÷ weighted average shares · filed 2024-02-16 | $5.49 10-Q · filed 2023-10-27 | $7.29 derived: net income ÷ weighted average shares · filed 2024-02-16 | |
| 2022-07-03 | $1.83 10-K · filed 2024-02-16 | $3.79 10-Q · filed 2023-07-31 | $5.59 derived: net income ÷ weighted average shares · filed 2024-02-16 | $6.98 derived: net income ÷ weighted average shares · filed 2024-02-16 | |
| 2022-04-03 | $1.96 10-K · filed 2024-02-16 | $3.76 derived: net income ÷ weighted average shares · filed 2024-02-16 | $5.15 derived: net income ÷ weighted average shares · filed 2024-02-16 | $7.54 derived: net income ÷ weighted average shares · filed 2024-02-16 | |
| 2022-01-02 | $1.80 derived: net income ÷ weighted average shares · filed 2024-02-16 | $3.19 derived: net income ÷ weighted average shares · filed 2024-02-16 | $5.58 derived: net income ÷ weighted average shares · filed 2024-02-16 | $7.93 10-K · filed 2024-02-16 | |
| 2021-10-03 | $1.39 10-Q · filed 2022-10-27 | $3.78 derived: net income ÷ weighted average shares · filed 2022-10-27 | $6.13 10-Q · filed 2022-10-27 | $6.79 derived: net income ÷ weighted average shares · filed 2023-02-16 | |
| 2021-07-04 | $2.38 10-Q · filed 2022-07-29 | $4.74 10-Q · filed 2022-07-29 | $5.40 derived: net income ÷ weighted average shares · filed 2023-02-16 | $6.75 derived: net income ÷ weighted average shares · filed 2023-02-16 | |
| 2021-04-04 | $2.35 10-Q · filed 2022-04-29 | $3.01 derived: net income ÷ weighted average shares · filed 2023-02-16 | $4.36 derived: net income ÷ weighted average shares · filed 2023-02-16 | $5.74 derived: net income ÷ weighted average shares · filed 2023-02-16 | |
| 2021-01-03 | $0.66 derived: net income ÷ weighted average shares · filed 2023-02-16 | $2.01 derived: net income ÷ weighted average shares · filed 2023-02-16 | $3.39 derived: net income ÷ weighted average shares · filed 2023-02-16 | $5.59 10-K · filed 2023-02-16 | |
| 2020-09-27 | $1.35 10-Q · filed 2021-10-29 | $2.73 derived: net income ÷ weighted average shares · filed 2021-10-29 | $4.93 10-Q · filed 2021-10-29 | $6.45 derived: net income ÷ weighted average shares · filed 2022-02-17 | |
| 2020-06-28 | $1.38 10-Q · filed 2021-07-29 | $3.58 10-Q · filed 2021-07-29 | $5.10 derived: net income ÷ weighted average shares · filed 2022-02-17 | $5.77 derived: net income ÷ weighted average shares · filed 2022-02-17 | |
| 2020-03-29 | $2.20 10-Q · filed 2021-04-30 | $3.72 derived: net income ÷ weighted average shares · filed 2022-02-17 | $4.39 derived: net income ÷ weighted average shares · filed 2022-02-17 | $6.51 derived: net income ÷ weighted average shares · filed 2022-02-17 | |
| 2019-12-29 | $1.52 10-K · filed 2020-02-18 | $2.19 derived: net income ÷ weighted average shares · filed 2022-02-17 | $4.31 derived: net income ÷ weighted average shares · filed 2022-02-17 | $5.72 10-K · filed 2022-02-17 | |
| 2019-09-29 | $0.67 10-Q · filed 2020-10-23 | $2.78 derived: net income ÷ weighted average shares · filed 2020-10-23 | $4.19 10-Q · filed 2020-10-23 | $5.33 derived: net income ÷ weighted average shares · filed 2021-02-22 | |
| 2019-06-30 | $2.11 10-Q · filed 2020-07-24 | $3.52 10-Q · filed 2020-07-24 | $4.65 derived: net income ÷ weighted average shares · filed 2021-02-22 | $6.12 derived: net income ÷ weighted average shares · filed 2021-02-22 | |
| 2019-03-31 | $1.41 10-Q · filed 2020-04-29 | $2.54 derived: net income ÷ weighted average shares · filed 2021-02-22 | $4.01 derived: net income ÷ weighted average shares · filed 2021-02-22 | $5.49 derived: net income ÷ weighted average shares · filed 2021-02-22 | |
| 2018-12-30 | $1.14 10-K · filed 2020-02-18 | $2.60 derived: net income ÷ weighted average shares · filed 2021-02-22 | $4.08 derived: net income ÷ weighted average shares · filed 2021-02-22 | $5.70 10-K · filed 2021-02-22 | |
| 2018-09-30 | $1.47 10-K · filed 2020-02-18 | $2.94 derived: net income ÷ weighted average shares · filed 2020-02-18 | $4.57 10-Q · filed 2019-10-28 | $0.57 derived: net income ÷ weighted average shares · filed 2020-02-18 | |
| 2018-07-01 | $1.47 10-K · filed 2020-02-18 | $3.10 10-Q · filed 2019-07-29 | -$0.89 derived: net income ÷ weighted average shares · filed 2020-02-18 | $0.51 derived: net income ÷ weighted average shares · filed 2020-02-18 | |
| 2018-04-01 | $1.63 10-K · filed 2020-02-18 | -$2.36 derived: net income ÷ weighted average shares · filed 2020-02-18 | -$0.96 derived: net income ÷ weighted average shares · filed 2020-02-18 | $0.46 derived: net income ÷ weighted average shares · filed 2020-02-18 | |
| 2017-12-31 | -$3.99 10-K · filed 2019-02-20 | -$2.59 derived: net income ÷ weighted average shares · filed 2020-02-18 | -$1.16 derived: net income ÷ weighted average shares · filed 2020-02-18 | $0.48 10-K · filed 2020-02-18 | |
| 2017-10-01 | $1.40 10-K · filed 2019-02-20 | $2.82 derived: net income ÷ weighted average shares · filed 2019-02-20 | $4.46 10-Q · filed 2018-10-31 | $5.86 derived: net income ÷ weighted average shares · filed 2019-02-20 | |
| 2017-07-02 | $1.42 10-K · filed 2019-02-20 | $3.06 10-Q · filed 2018-08-02 | $4.46 derived: net income ÷ weighted average shares · filed 2019-02-20 | $6.03 derived: net income ÷ weighted average shares · filed 2019-02-20 | |
| 2017-04-02 | $1.63 10-K · filed 2019-02-20 | $3.04 derived: net income ÷ weighted average shares · filed 2019-02-20 | $4.60 derived: net income ÷ weighted average shares · filed 2019-02-20 | $6.06 derived: net income ÷ weighted average shares · filed 2019-02-20 | |
| 2017-01-01 | $1.41 10-K · filed 2018-02-21 | $2.97 derived: net income ÷ weighted average shares · filed 2019-02-20 | $4.43 derived: net income ÷ weighted average shares · filed 2019-02-20 | $6.04 10-K · filed 2019-02-20 | |
| 2016-10-02 | $1.56 10-K · filed 2018-02-21 | $3.02 derived: net income ÷ weighted average shares · filed 2018-02-21 | $4.64 10-Q · filed 2017-11-02 | $5.80 derived: net income ÷ weighted average shares · filed 2018-02-21 | |
| 2016-07-03 | $1.46 10-K · filed 2018-02-21 | $3.07 10-Q · filed 2017-08-03 | $4.24 derived: net income ÷ weighted average shares · filed 2018-02-21 | $5.45 derived: net income ÷ weighted average shares · filed 2018-02-21 | |
| 2016-04-03 | $1.62 10-K · filed 2018-02-21 | $1.56 10-Q · filed 2016-05-10 | $2.78 derived: net income ÷ weighted average shares · filed 2018-02-21 | $3.99 derived: net income ÷ weighted average shares · filed 2018-02-21 | $5.62 derived: net income ÷ weighted average shares · filed 2018-02-21 |
| 2016-01-03 | $1.16 10-K · filed 2017-02-27 | $2.38 derived: net income ÷ weighted average shares · filed 2018-02-21 | $4.01 derived: net income ÷ weighted average shares · filed 2018-02-21 | $5.56 10-K · filed 2018-02-21 | |
| 2015-09-27 | $1.21 10-K · filed 2017-02-27 | $2.84 derived: net income ÷ weighted average shares · filed 2017-02-27 | $4.39 10-Q · filed 2016-11-04 | $5.29 derived: net income ÷ weighted average shares · filed 2017-02-27 | |
| 2015-06-28 | $1.63 10-K · filed 2017-02-27 | $3.18 10-Q · filed 2016-08-04 | $4.08 derived: net income ÷ weighted average shares · filed 2017-02-27 | $5.77 derived: net income ÷ weighted average shares · filed 2017-02-27 | |
| 2015-03-29 | $1.55 10-K · filed 2017-02-27 | $2.45 derived: net income ÷ weighted average shares · filed 2017-02-27 | $4.14 derived: net income ÷ weighted average shares · filed 2017-02-27 | $5.68 derived: net income ÷ weighted average shares · filed 2017-02-27 | |
| 2014-12-28 | $0.90 10-K · filed 2016-02-24 | $2.59 derived: net income ÷ weighted average shares · filed 2017-02-27 | $4.12 derived: net income ÷ weighted average shares · filed 2017-02-27 | $5.80 10-K · filed 2017-02-27 | |
| 2014-09-28 | $1.69 10-K · filed 2016-02-24 | $3.22 derived: net income ÷ weighted average shares · filed 2016-02-24 | $4.89 10-Q · filed 2015-10-30 | $6.14 derived: net income ÷ weighted average shares · filed 2016-02-24 | |
| 2014-06-29 | $1.53 10-K · filed 2016-02-24 | $3.20 10-Q · filed 2015-07-31 | $4.45 derived: net income ÷ weighted average shares · filed 2016-02-24 | $5.51 derived: net income ÷ weighted average shares · filed 2016-02-24 | |
| 2014-03-30 | $1.67 10-K · filed 2016-02-24 | $2.92 derived: net income ÷ weighted average shares · filed 2016-02-24 | $3.98 derived: net income ÷ weighted average shares · filed 2016-02-24 | $5.34 derived: net income ÷ weighted average shares · filed 2016-02-24 | |
| 2013-12-29 | $1.25 10-K · filed 2015-02-24 | $2.31 derived: net income ÷ weighted average shares · filed 2016-02-24 | $3.67 derived: net income ÷ weighted average shares · filed 2016-02-24 | $4.92 10-K · filed 2016-02-24 | |
| 2013-09-29 | $1.06 10-K · filed 2015-02-24 | $2.42 derived: net income ÷ weighted average shares · filed 2015-02-24 | $3.68 10-Q · filed 2014-10-30 | $4.60 derived: net income ÷ weighted average shares · filed 2015-02-24 | |
| 2013-06-30 | $1.36 10-K · filed 2015-02-24 | $2.62 10-Q · filed 2014-08-01 | $3.55 derived: net income ÷ weighted average shares · filed 2015-02-24 | $4.62 derived: net income ÷ weighted average shares · filed 2015-02-24 | |
| 2013-03-31 | $1.25 10-K · filed 2015-02-24 | $2.18 derived: net income ÷ weighted average shares · filed 2015-02-24 | $3.26 derived: net income ÷ weighted average shares · filed 2015-02-24 | $3.77 derived: net income ÷ weighted average shares · filed 2015-02-24 | |
| 2012-12-30 | $0.93 10-K · filed 2014-02-21 | $2.00 derived: net income ÷ weighted average shares · filed 2015-02-24 | $2.52 derived: net income ÷ weighted average shares · filed 2015-02-24 | $3.94 10-K · filed 2015-02-24 | |
| 2012-09-30 | $1.08 10-K · filed 2014-02-21 | $1.59 derived: net income ÷ weighted average shares · filed 2014-02-21 | $3.02 10-Q · filed 2013-11-04 | $3.10 derived: net income ÷ weighted average shares · filed 2014-02-21 | |
| 2012-07-01 | $0.51 10-K · filed 2014-02-21 | $1.94 10-Q · filed 2013-08-01 | $2.02 derived: net income ÷ weighted average shares · filed 2014-02-21 | $3.19 derived: net income ÷ weighted average shares · filed 2014-02-21 | |
| 2012-04-01 | $1.43 10-K · filed 2014-02-21 | $1.51 derived: net income ÷ weighted average shares · filed 2014-02-21 | $2.68 derived: net income ÷ weighted average shares · filed 2014-02-21 | $3.69 derived: net income ÷ weighted average shares · filed 2014-02-21 | |
| 2012-01-01 | $0.08 10-K · filed 2013-02-22 | $1.25 derived: net income ÷ weighted average shares · filed 2014-02-21 | $2.27 derived: net income ÷ weighted average shares · filed 2014-02-21 | $3.54 10-K · filed 2014-02-21 | |
| 2011-10-02 | $1.17 10-K · filed 2013-02-22 | $2.18 derived: net income ÷ weighted average shares · filed 2013-02-22 | $3.45 10-Q · filed 2012-11-09 | $4.16 derived: net income ÷ weighted average shares · filed 2013-02-22 | |
| 2011-07-03 | $1.01 10-K · filed 2013-02-22 | $2.28 10-Q · filed 2012-08-02 | $2.99 derived: net income ÷ weighted average shares · filed 2013-02-22 | $4.23 derived: net income ÷ weighted average shares · filed 2013-02-22 | |
| 2011-04-03 | $1.27 10-K · filed 2013-02-22 | $1.98 derived: net income ÷ weighted average shares · filed 2013-02-22 | $3.22 derived: net income ÷ weighted average shares · filed 2013-02-22 | $4.47 derived: net income ÷ weighted average shares · filed 2013-02-22 | |
| 2011-01-02 | $0.71 10-K · filed 2012-02-23 | $1.95 derived: net income ÷ weighted average shares · filed 2013-02-22 | $3.20 derived: net income ÷ weighted average shares · filed 2013-02-22 | $4.85 10-K · filed 2013-02-22 | |
| 2010-10-03 | $1.24 10-K · filed 2012-02-23 | $2.49 derived: net income ÷ weighted average shares · filed 2012-02-23 | $4.14 10-Q · filed 2011-11-08 | $4.94 derived: net income ÷ weighted average shares · filed 2012-02-23 | |
| 2010-07-04 | $1.25 10-K · filed 2012-02-23 | $2.89 10-Q · filed 2011-08-09 | $3.69 derived: net income ÷ weighted average shares · filed 2012-02-23 | $4.91 derived: net income ÷ weighted average shares · filed 2012-02-23 | |
| 2010-04-04 | $1.64 10-K · filed 2012-02-23 | $2.44 derived: net income ÷ weighted average shares · filed 2012-02-23 | $3.66 derived: net income ÷ weighted average shares · filed 2012-02-23 | $4.82 derived: net income ÷ weighted average shares · filed 2012-02-23 | |
| 2010-01-03 | $0.80 10-K · filed 2011-02-25 | $2.01 derived: net income ÷ weighted average shares · filed 2012-02-23 | $3.18 derived: net income ÷ weighted average shares · filed 2012-02-23 | $4.45 10-K · filed 2012-02-23 | |
| 2009-09-27 | $1.21 10-K · filed 2011-02-25 | $2.38 derived: net income ÷ weighted average shares · filed 2011-02-25 | $3.64 10-Q · filed 2010-11-10 | ||
| 2009-06-28 | $1.16 10-K · filed 2011-02-25 | $2.43 10-Q · filed 2010-08-11 | |||
| 2009-03-29 | $1.27 10-K · filed 2011-02-25 | ||||
| 2008-12-28 | $4.62 10-K · filed 2011-02-25 | ||||
| 2008-09-28 | $1.19 10-Q · filed 2009-11-04 | $3.64 10-Q · filed 2009-11-04 | |||
| 2008-06-29 | $1.18 10-Q · filed 2009-08-04 | $2.45 10-Q · filed 2009-08-04 | |||
| 2007-12-30 | $3.67 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ELI LILLY & Co (LLY) | United States | $1,113.804B | 42.28 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |